Geron (GERN) Shares Issued (2010 - 2024)
Geron (GERN) posted Shares Issued of $74.2 million for Q4 2024, up 85.42% sequentially from $40.0 million in Q4 2023, and up 85.42% YoY from $40.0 million in Q1 2024.
Geron (GERN) Shares Issued (2010 - 2024) Analysis & Trends
Geron has reported Shares Issued for 15 years, with the latest figure at $74.2 million in Q4 2024.
- Quarterly Shares Issued rose 85.42% year-over-year to $74.2 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $74.2 million (up 85.42% YoY) and the FY2024 annual result came in at $74.2 million, up 85.42% from the prior year.
- Shares Issued advanced to $74.2 million in Q4 2024 per GERN's latest filing, from $40.0 million in the prior quarter.
- Over five years, Shares Issued peaked at $74.2 million in Q4 2024 and troughed at $25.7 million in Q4 2020.
- A 5-year average of $41.3 million and a median of $36.1 million in 2022 frame the typical range for Shares Issued.
- The sharpest annual moves came in 2023 and 2024: Shares Issued grew 10.84% in 2023, then soared 85.42% in 2024.
- Over 5 years, Shares Issued stood at $25.7 million in 2020, then grew by 18.42% to $30.5 million in 2021, then advanced by 18.47% to $36.1 million in 2022, then climbed by 10.84% to $40.0 million in 2023, then jumped by 85.42% to $74.2 million in 2024.
- According to Business Quant data, Shares Issued over the past three periods registered $74.2 million, $40.0 million, and $36.1 million for Q4 2024, Q4 2023, and Q4 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Geron | 1.02 Mn | -299.83 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 74.16 Mn |
| Dec 31, 2024 | 74.16 Mn |
| Dec 31, 2023 | 40.00 Mn |
| Dec 31, 2023 | 40.00 Mn |
| Dec 31, 2022 | 36.09 Mn |
| Dec 31, 2022 | 36.09 Mn |
| Dec 31, 2021 | 30.46 Mn |
| Dec 31, 2021 | 30.46 Mn |
| Dec 31, 2020 | 25.72 Mn |
| Dec 31, 2020 | 25.72 Mn |
| Dec 31, 2019 | 19.92 Mn |
| Dec 31, 2019 | 19.92 Mn |
| Dec 31, 2018 | 16.46 Mn |
| Dec 31, 2018 | 16.46 Mn |
| Dec 31, 2017 | 17.25 Mn |
| Dec 31, 2017 | 17.25 Mn |
| Dec 31, 2016 | 14.07 Mn |
| Dec 31, 2016 | 14.07 Mn |
| Dec 31, 2015 | 11.36 Mn |
| Dec 31, 2015 | 11.36 Mn |